AIHC Fund

CS Capital is one of the largest professional private equity investment firms in China with over US$16 billion (RMB100 billion) of AUM from a diversified LP base. Our core strategy is to invest in companies with attractive prospects for growth and outstanding management teams in smart EV, life science and digitalization sectors. *

	Start	2022-03-04 existent
	Industry	private equity
	Industry 2	LIFE SCIENCES

	Region	China_oo
	Country	China
	City	n. a.
		Address record changed: 2022-05-25

Basic data	Employees	n. a.

		* Document for »About Section«: InxMed Co., Ltd.. (3/4/22). "Press Release: InxMed Raised $50 Million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers". Nanjing.

		Record changed: 2022-05-25

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]